Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.53 USD | +1.28% |
|
+21.74% | +31.46% |
Jul. 02 | Inozyme Pharma Says US FDA Granted Fast Track Designation to INZ-701 to Treat ABCC6 Deficiency | MT |
Jul. 02 | Inozyme Pharma Gets FDA Fast Track Designation for INZ-701 in ABCC6 Deficiency | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.46% | 338M | |
+26.63% | 46.56B | |
+45.26% | 41.67B | |
-0.47% | 41.16B | |
+34.37% | 32.4B | |
+20.78% | 28.18B | |
-6.35% | 28.1B | |
+49.53% | 14.52B | |
+47.01% | 13.74B | |
+1.76% | 12.17B |
- Stock Market
- Equities
- INZY Stock
- News Inozyme Pharma, Inc.
- Insider Buy: Inozyme Pharma